Wednesday's Underperforming Sectors: Technology, Healthcare Facilities, and Medical Professionals
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 03 2025
0mins
Source: NASDAQ.COM
Market Performance: Hospital and medical practitioners' shares are down approximately 1% on Wednesday, with Acadia Healthcare and PACS Group leading the decline.
Notable Declines: Acadia Healthcare's shares fell by about 12.3%, while PACS Group's shares decreased by around 5.6%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PACS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PACS
Wall Street analysts forecast PACS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PACS is 42.60 USD with a low forecast of 40.00 USD and a high forecast of 47.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 34.350
Low
40.00
Averages
42.60
High
47.00
Current: 34.350
Low
40.00
Averages
42.60
High
47.00
About PACS
PACS Group, Inc. is a holding company investing in post-acute healthcare facilities, professionals, and ancillary services. The Company is focused on delivering skilled nursing care through a portfolio of independently operated facilities. It also provides its independently operated facilities with a comprehensive suite of technology, support, and back-office services. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. The Company’s independent subsidiaries operate about 314 post-acute care and senior living facilities across 17 states, serving over 30,000 patients daily.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
PACS Group Acquires Three Post-Acute Care Facilities, Adding 230 Beds
- Network Expansion: PACS Group's acquisition of three post-acute care facilities in Alaska and Idaho adds 230 beds, significantly enhancing its market share and service capabilities in the post-acute care sector.
- Real Estate Acquisition: The deal includes the acquisition of real estate for two facilities in Alaska, while the Idaho facility will operate under a lease with a third-party landlord, demonstrating PACS's flexibility in asset management.
- Strategic Growth Focus: CEO Jason Murray stated that these acquisitions align with the company's core platform, aiming to achieve long-term performance growth by expanding high-acuity care services in strong markets.
- National Impact Enhancement: This expansion brings PACS's total community count to 324 across 17 states, serving over 31,000 patients, further solidifying its leadership position in the national post-acute care industry.
Continue Reading
Crewe Advisors Acquires 1,035,747 Shares of PACS Group for $22.72 Million
- Share Acquisition: Crewe Advisors disclosed in an SEC filing on January 16 that it acquired 1,035,747 shares of PACS Group for an estimated $22.72 million, indicating strong confidence in the company.
- Asset Growth: Following this transaction, Crewe Advisors' total holdings in PACS Group reached $82.45 million, a net increase of $67.19 million from the previous quarter, reflecting both new purchases and price appreciation.
- Market Performance: As of January 15, PACS shares were priced at $39.37, up 184.9% over the past year, significantly outperforming the S&P 500 by 168.16 percentage points, showcasing its robust growth potential in the post-acute healthcare sector.
- Financial Health: PACS Group reported third-quarter revenue of $1.34 billion, a 31% year-over-year increase, with adjusted EBITDA of $131.5 million and operating cash flow exceeding $400 million, indicating its sustained cash generation capability in a defensive growth industry.
Continue Reading